[Ambulatory testing of a new antihistaminic. Experience with Tavegil].
D004485:Eczema / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000188:drug therapy*; D009450:Neurodermatitis / Q000188:drug therapy; D011537:Pruritus / Q000188:drug therapy; D014581:Urticaria / Q000188:drug therapy
D006634:Histamine H1 Antagonists
Ambulante Prüfung eines neuen Antihistaminikums. Erfahrungen mit Tavegil.